PCN89 DRUG UTILIZATION PATTERNS AND COSTS FOR ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN A MANAGED CARE CANCER POPULATION RECEIVING CHEMOTHERAPY
Abstract
Authors
A Gosselin MH Lafeuille B Bookhart P Lefebvre RS Mckenzie F Vekeman CT Piech